These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 29359533)

  • 1. The City of Johannesburg can end AIDS by 2030: modelling the impact of achieving the Fast-Track targets and what it will take to get there.
    Stuart RM; Fraser-Hurt N; Kerr CC; Mabusela E; Madi V; Mkhwanazi F; Pillay Y; Barron P; Muzah B; Matsebula T; Gorgens M; Wilson DP
    J Int AIDS Soc; 2018 Jan; 21(1):. PubMed ID: 29359533
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impact and Cost of Scaling Up Voluntary Medical Male Circumcision for HIV Prevention in the Context of the New 90-90-90 HIV Treatment Targets.
    Kripke K; Reed J; Hankins C; Smiley G; Laube C; Njeuhmeli E
    PLoS One; 2016; 11(10):e0155734. PubMed ID: 27783681
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impact and Cost of the HIV/AIDS National Strategic Plan for Mozambique, 2015-2019--Projections with the Spectrum/Goals Model.
    Korenromp EL; Gobet B; Fazito E; Lara J; Bollinger L; Stover J
    PLoS One; 2015; 10(11):e0142908. PubMed ID: 26565696
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Population-level impact of an accelerated HIV response plan to reach the UNAIDS 90-90-90 target in Côte d'Ivoire: Insights from mathematical modeling.
    Maheu-Giroux M; Vesga JF; Diabaté S; Alary M; Baral S; Diouf D; Abo K; Boily MC
    PLoS Med; 2017 Jun; 14(6):e1002321. PubMed ID: 28617810
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Future HIV epidemic trajectories in South Africa and projected long-term consequences of reductions in general population HIV testing: a mathematical modelling study.
    Rautenbach SP; Whittles LK; Meyer-Rath G; Jamieson L; Chidarikire T; Johnson LF; Imai-Eaton JW
    Lancet Public Health; 2024 Apr; 9(4):e218-e230. PubMed ID: 38553141
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Optimizing HIV/AIDS resources in Armenia: increasing ART investment and examining HIV programmes for seasonal migrant labourers.
    Kelly SL; Shattock AJ; Kerr CC; Stuart RM; Papoyan A; Grigoryan T; Hovhannisyan R; Grigoryan S; Benedikt C; Wilson DP
    J Int AIDS Soc; 2016; 19(1):20772. PubMed ID: 27281790
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Scale-Up of Voluntary Medical Male Circumcision Services for HIV Prevention - 12 Countries in Southern and Eastern Africa, 2013-2016.
    Hines JZ; Ntsuape OC; Malaba K; Zegeye T; Serrem K; Odoyo-June E; Nyirenda RK; Msungama W; Nkanaunena K; Come J; Canda M; Nhaguiombe H; Shihepo EK; Zemburuka BLT; Mutandi G; Yoboka E; Mbayiha AH; Maringa H; Bere A; Lawrence JJ; Lija GJI; Simbeye D; Kazaura K; Mwiru RS; Talisuna SA; Lubwama J; Kabuye G; Zulu JE; Chituwo O; Mumba M; Xaba S; Mandisarisa J; Baack BN; Hinkle L; Grund JM; Davis SM; Toledo C
    MMWR Morb Mortal Wkly Rep; 2017 Dec; 66(47):1285-1290. PubMed ID: 29190263
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Towards achieving the 90-90-90 HIV targets: results from the south African 2017 national HIV survey.
    Marinda E; Simbayi L; Zuma K; Zungu N; Moyo S; Kondlo L; Jooste S; Nadol P; Igumbor E; Dietrich C; Briggs-Hagen M
    BMC Public Health; 2020 Sep; 20(1):1375. PubMed ID: 32907565
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Progress and prospects for the control of HIV and tuberculosis in South Africa: a dynamical modelling study.
    Williams BG; Gupta S; Wollmers M; Granich R
    Lancet Public Health; 2017 May; 2(5):e223-e230. PubMed ID: 29253488
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Modeling the epidemiological impact of the UNAIDS 2025 targets to end AIDS as a public health threat by 2030.
    Stover J; Glaubius R; Teng Y; Kelly S; Brown T; Hallett TB; Revill P; Bärnighausen T; Phillips AN; Fontaine C; Frescura L; Izazola-Licea JA; Semini I; Godfrey-Faussett P; De Lay PR; Benzaken AS; Ghys PD
    PLoS Med; 2021 Oct; 18(10):e1003831. PubMed ID: 34662333
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Achieving the HIV prevention impact of voluntary medical male circumcision: lessons and challenges for managing programs.
    Sgaier SK; Reed JB; Thomas A; Njeuhmeli E
    PLoS Med; 2014 May; 11(5):e1001641. PubMed ID: 24800840
    [TBL] [Abstract][Full Text] [Related]  

  • 12. What Is Required to End the AIDS Epidemic as a Public Health Threat by 2030? The Cost and Impact of the Fast-Track Approach.
    Stover J; Bollinger L; Izazola JA; Loures L; DeLay P; Ghys PD;
    PLoS One; 2016; 11(5):e0154893. PubMed ID: 27159260
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The global Optima HIV allocative efficiency model: targeting resources in efforts to end AIDS.
    Kelly SL; Martin-Hughes R; Stuart RM; Yap XF; Kedziora DJ; Grantham KL; Hussain SA; Reporter I; Shattock AJ; Grobicki L; Haghparast-Bidgoli H; Skordis-Worrall J; Baranczuk Z; Keiser O; Estill J; Petravic J; Gray RT; Benedikt CJ; Fraser N; Gorgens M; Wilson D; Kerr CC; Wilson DP
    Lancet HIV; 2018 Apr; 5(4):e190-e198. PubMed ID: 29540265
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The emerging health impact of voluntary medical male circumcision in Zimbabwe: An evaluation using three epidemiological models.
    McGillen JB; Stover J; Klein DJ; Xaba S; Ncube G; Mhangara M; Chipendo GN; Taramusi I; Beacroft L; Hallett TB; Odawo P; Manzou R; Korenromp EL
    PLoS One; 2018; 13(7):e0199453. PubMed ID: 30020940
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Voluntary medical male circumcision: modeling the impact and cost of expanding male circumcision for HIV prevention in eastern and southern Africa.
    Njeuhmeli E; Forsythe S; Reed J; Opuni M; Bollinger L; Heard N; Castor D; Stover J; Farley T; Menon V; Hankins C
    PLoS Med; 2011 Nov; 8(11):e1001132. PubMed ID: 22140367
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effectiveness of and Financial Returns to Voluntary Medical Male Circumcision for HIV Prevention in South Africa: An Incremental Cost-Effectiveness Analysis.
    Haacker M; Fraser-Hurt N; Gorgens M
    PLoS Med; 2016 May; 13(5):e1002012. PubMed ID: 27138961
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effect of 90-90-90 on HIV-1 incidence and mortality in eSwatini: a mathematical modelling study.
    Akullian A; Morrison M; Garnett GP; Mnisi Z; Lukhele N; Bridenbecker D; Bershteyn A
    Lancet HIV; 2020 May; 7(5):e348-e358. PubMed ID: 32061317
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Towards achieving the fast-track targets and ending the epidemic of HIV/AIDS in Ethiopia: Successes and challenges.
    Assefa Y; Gilks CF; Dean J; Tekle B; Lera M; Balcha TT; Getaneh Y; Van Damme W; Hill PS
    Int J Infect Dis; 2019 Jan; 78():57-64. PubMed ID: 30391417
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Factors associated with the take-up of voluntary medical male circumcision amongst learners in rural KwaZulu-Natal.
    George G; Govender K; Beckett S; Montague C; Frohlich J
    Afr J AIDS Res; 2017 Sep; 16(3):251-256. PubMed ID: 28978292
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The HIV care continuum for sexually active transgender women in three metropolitan municipalities in South Africa: findings from a biobehavioural survey 2018-19.
    Cloete A; Mabaso M; Savva H; van der Merwe LL; Naidoo D; Petersen Z; Kose Z; Mthembu J; Moyo S; Skinner D; Jooste S; Fellows IE; Shiraishi RW; Mwandingi SL; Simbayi LC
    Lancet HIV; 2023 Jun; 10(6):e375-e384. PubMed ID: 37119825
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.